display

After the approval of the corona vaccine from Johnson & Johnson, Federal Minister of Health Jens Spahn does not expect deliveries immediately.

The CDU politician said on Thursday in the ARD “Tagesthemen”: “The truth is that deliveries cannot be expected until mid-April at the earliest, according to Johnson & Johnson.” Now they want to know exactly why other countries would be supplied and whether the European Union could be on it as soon as possible.

The European Commission is conducting the talks.

The vaccine is bottled in the USA - there is a de facto export ban for corona vaccines.

Spahn said that over the past twelve months one had to experience again and again that "certain products have not left the USA" with drugs and tests.

"I find this problematic, also in terms of being together in the transatlantic partnership." This must now be discussed with the partners.

Now we have to deal with the situation first and ensure that there are more productions in Germany and Europe - including the vaccine from Johnson & Johnson.

EU Commission approves Johnson & Johnson

The EU Commission approved the corona vaccine from the US company Johnson & Johnson on Thursday.

The European Medicines Agency EMA had previously given the go-ahead for this.

display

Johnson & Johnson's vaccine is the fourth corona vaccine to receive EU-wide approval after the active ingredients from Biontech / Pfizer, Moderna and AstraZeneca.

The vaccine is around 85 percent effective against severe Covid 19 diseases.

A key benefit of the Johnson & Johnson vector virus vaccine is that only one dose is required.

It can also be stored at normal refrigerator temperatures.

The vaccine could therefore greatly accelerate vaccination programs in Europe.

"With the amount of cans ordered, we could vaccinate up to 200 million people in the EU," said von der Leyen.

The EU also holds an option for 200 million more doses of the active ingredient.

display

Buy antigen self-tests online now

Take a nasal swab, read the result on the test strip within 15 minutes and find out whether you have Covid-19.

Order 10 pieces from APONEO Order 25 pieces from APONEO

display

In the EU, however, doubts have already arisen as to whether the US company can keep its promises.

Johnson & Johnson is expected to deliver 55 million cans by the end of June.

From EU circles, however, it was reported that the first deliveries were not expected until mid-April at the earliest.

At the end of January, Johnson & Johnson reported an effectiveness of 66 percent for the agent in protecting against moderate to severe Covid-19 courses in its global study with around 44,000 participants.

In preventing hospitalization, the vaccine was 85 percent effective 14 days after vaccination and 100 percent effective at 28 days.

The vaccine is already approved in the US, Canada and Bahrain.

The responsible committee of the EMA had recommended conditional approval of the vaccine for people aged 18 and over.